Scott Dreyer Collegium Pharmaceutical, Inc (COLL) insider trading activity

Scott Dreyer is EVP & Chief Commercial Officer of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 124,421 shares of COLL, which is worth approximately $3.72 Million. The most recent transaction as insider was on Mar 14, 2025, when has been sold 2,255 shares (Common Stock) at a price of $30.0 per share, resulting in proceeds of $67,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K

17.49% 3M change

10.44% 12M change

Total Value Held $3.72 Million

Scott Dreyer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2025	SELL Open market or private sale	$67,650 $30.0 p/Share	2,255 Reduced 1.78%	124,421 Common Stock
Mar 07 2025	SELL Open market or private sale	$70,440 $30.0 p/Share	2,348 Reduced 1.63%	142,063 Common Stock
Mar 06 2025	SELL Open market or private sale	$461,610 $30.0 p/Share	15,387 Reduced 10.83%	126,676 Common Stock
Mar 06 2025	SELL Open market or private sale	$98,850 $30.0 p/Share	3,295 Reduced 2.23%	144,411 Common Stock
Feb 10 2025	SELL Payment of exercise price or tax liability	$904,093 $30.52 p/Share	29,623 Reduced 16.71%	147,706 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	71,427 Added 28.71%	177,329 Common Stock
May 24 2024	SELL Open market or private sale	$1,930,301 $33.98 p/Share	56,807 Reduced 34.91%	105,902 Common Stock
May 24 2024	BUY Exercise of conversion of derivative security	$571,697 $24.03 p/Share	23,791 Added 12.76%	162,709 Common Stock
May 23 2024	SELL Open market or private sale	$1,731,888 $33.82 p/Share	51,209 Reduced 26.93%	138,918 Common Stock
May 23 2024	BUY Exercise of conversion of derivative security	$1,230,552 $24.03 p/Share	51,209 Added 21.22%	190,127 Common Stock
Feb 26 2024	SELL Open market or private sale	$367,700 $36.77 p/Share	10,000 Reduced 6.72%	138,918 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$1,000,553 $33.7 p/Share	29,690 Reduced 16.62%	148,918 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	67,286 Added 27.36%	178,608 Common Stock
Jan 16 2024	SELL Open market or private sale	$760,516 $32.28 p/Share	23,560 Reduced 17.47%	111,322 Common Stock
Mar 01 2023	SELL Open market or private sale	$355,750 $26.7 p/Share	13,324 Reduced 8.99%	134,882 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$570,470 $26.75 p/Share	21,326 Reduced 12.58%	148,206 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	66,734 Added 28.25%	169,532 Common Stock
Jan 09 2023	SELL Open market or private sale	$496,320 $27.83 p/Share	17,834 Reduced 14.78%	102,798 Common Stock
Jul 11 2022	SELL Payment of exercise price or tax liability	$10,383 $17.48 p/Share	594 Reduced 0.49%	120,632 Common Stock
Feb 18 2022	SELL Open market or private sale	$228,180 $21.61 p/Share	10,559 Reduced 8.01%	121,226 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$187,918 $17.63 p/Share	10,659 Reduced 7.48%	131,785 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	66,175 Added 31.72%	142,444 Common Stock
Jan 10 2022	SELL Payment of exercise price or tax liability	$13,354 $19.05 p/Share	701 Reduced 0.91%	76,269 Common Stock
Dec 15 2021	SELL Open market or private sale	$104,353 $18.33 p/Share	5,693 Reduced 6.89%	76,970 Common Stock
Jul 12 2021	SELL Payment of exercise price or tax liability	$13,786 $23.17 p/Share	595 Reduced 0.71%	82,663 Common Stock

Scott Dreyer

EVP & Chief Commercial Officer

Stoughton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Value

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL

Account